WebJul 11, 2024 · Dynavax Technologies has 200 employees, and the revenue per employee ratio is $232,755. Dynavax Technologies's peak quarterly revenue was $19.6M in 2024 (Q4). Dynavax Technologies peak revenue was $46.6M in 2024. Dynavax Technologies annual revenue for 2024 was $35.2M, a 329.6% growth from 2024. Dynavax … WebNov 4, 2024 · Dynavax Technologies Corporation today reported financial results for the third quarter ended September 30, 2024 and provided a business update. ... CpG 1018 and financial commitments made to them, as well as other risks detailed in the "Risk Factors" section of our Annual Report on Form 10-K for the fiscal year ended December 31, ...
Dynavax Technologies Corporation (DVAX) Earnings Report
WebFeb 28, 2024 · Dynavax generated $120.5 million in cash from operations in the fourth quarter of 2024, compared to cash used in operations of $15.7 million in the fourth quarter of 2024. The Company generated... WebFeb 23, 2024 · HEPLISAV-B vaccine achieved record annual net product revenue of $125.9 million for 2024, compared to $61.9 million for 2024, representing annual growth of 104%. left anterior scalenectomy
Dynavax Reports Fourth Quarter and Full Year 2024 Financial …
WebFeb 23, 2024 · Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2024 Financial Guidance Feb 23, 2024 (PRNewswire via COMTEX) -- PR Newswire EMERYVILLE, Calif., Feb.... WebDynavax Reports Third Quarter 2024 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient Populations. Form 10-Q. Second Quarter. … Dynavax Technologies Corporate Presentation. Upcoming Events. More … Dynavax Technologies Corporation is followed by the analysts listed above. … WebAug 6, 2024 · Information on Dynavax's website at www.dynavax.com is not incorporated by reference in our current periodic reports with the SEC. Contacts: Nicole Arndt , Senior Manager, Investor Relations ... left anterior talofibular ligament